2-PHENOXYETHYL 2-(3-OXO-2-PIPERAZINYL)ACETATE
- $110 - $795.8
- Product name: 2-PHENOXYETHYL 2-(3-OXO-2-PIPERAZINYL)ACETATE
- CAS: 1024712-63-7
- MF: C14H18N2O4
- MW: 278.3
- EINECS:
- MDL Number:MFCD05666736
- Synonyms:2-PHENOXYETHYL 2-(3-OXO-2-PIPERAZINYL)ACETATE;2-Piperazineacetic acid, 3-oxo-, 2-phenoxyethyl ester
4 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- Matrix Scientific
- TRC
Package
- 50mg
- 500MG
- 1g
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0084322
- Product description2-PHENOXYETHYL 2-(3-OXO-2-PIPERAZINYL)ACETATE 95.00%
- Packaging500MG
- Price$795.8
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number023899
- Product description2-Phenoxyethyl 2-(3-oxo-2-piperazinyl)acetate
- Packaging1g
- Price$306
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number023899
- Product description2-Phenoxyethyl 2-(3-oxo-2-piperazinyl)acetate
- Packaging500mg
- Price$199
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberP399913
- Product description2-Phenoxyethyl2-(3-oxo-2-piperazinyl)acetate
- Packaging50mg
- Price$110
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
American Custom Chemicals Corporation | CHM0084322 | 2-PHENOXYETHYL 2-(3-OXO-2-PIPERAZINYL)ACETATE 95.00% | 500MG | $795.8 | 2021-12-16 | Buy |
Matrix Scientific | 023899 | 2-Phenoxyethyl 2-(3-oxo-2-piperazinyl)acetate | 1g | $306 | 2021-12-16 | Buy |
Matrix Scientific | 023899 | 2-Phenoxyethyl 2-(3-oxo-2-piperazinyl)acetate | 500mg | $199 | 2021-12-16 | Buy |
TRC | P399913 | 2-Phenoxyethyl2-(3-oxo-2-piperazinyl)acetate | 50mg | $110 | 2021-12-16 | Buy |
Properties
Boiling point :481.6±35.0 °C(Predicted)
Density :1.171±0.06 g/cm3(Predicted)
pka :15.01±0.40(Predicted)
Density :1.171±0.06 g/cm3(Predicted)
pka :15.01±0.40(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|